Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2012-11-28 08:01 |
VIVALIS RECOIT LE PRIX DE LA RELATION ACTIONNAIRES
|
French | 161.2 KB | ||
| 2012-11-28 08:00 |
VIVALIS RECEIVES PRIZE FOR INVESTOR RELATIONS
|
English | 155.2 KB | ||
| 2012-11-26 17:40 |
VIVALIS ANNONCE UN NOUVEAU DEPÔT DE DOSSIER D'ENREGISTREMENT POUR AUTORISATION …
|
French | 129.0 KB | ||
| 2012-11-26 17:40 |
VIVALIS ANNOUNCES A NEW REGISTRATION DOSSIER SUBMISSION OF AN EB66® BASED VACCI…
|
English | 119.5 KB | ||
| 2012-11-13 17:40 |
VIVALIS ANNONCE LA SIGNATURE D'UN NOUVEL ACCORD DE RECHERCHE POUR TESTER LA PRO…
|
French | 390.5 KB | ||
| 2012-11-13 17:40 |
VIVALIS ANNOUNCES A NEW EB66® RESEARCH AGREEMENT FOR THE ASSESSMENT OF MANUFACT…
|
English | 395.7 KB | ||
| 2012-11-09 08:31 |
VIVALIS WINS A 2012 DELOITTE TECHNOLOGY FAST 50 WEST AWARD
|
English | 148.1 KB | ||
| 2012-11-09 08:30 |
VIVALIS LAUREAT DU PRIX DELOITTE TECHNOLOGY FAST 50 OUEST 2012
|
French | 147.7 KB | ||
| 2012-11-06 17:40 |
VIVALIS ANNOUNCES A NEW EB66® TECHNOLOGY RESEARCH LICENSE WITH KYOTO BIKEN LABO…
|
English | 400.8 KB | ||
| 2012-11-06 17:40 |
VIVALIS ANNONCE LA SIGNATURE D'UNE NOUVELLE LICENCE DE RECHERCHE AVEC LES LABOR…
|
French | 396.9 KB | ||
| 2012-11-02 17:45 |
VIVALIS : ACTIONS ET DROITS DE VOTE OCTOBRE 2012
|
English | 134.5 KB | ||
| 2012-10-30 17:40 |
VIVALIS ANNONCE LA SIGNATURE D'UNE NOUVELLE LICENCE DE RECHERCHE POUR L'UTILISA…
|
French | 32.8 KB | ||
| 2012-10-30 17:40 |
VIVALIS ANNOUNCES A NEW EB66® CELL LINE RESEARCH LICENSE WITH A GLOBAL ANIMAL H…
|
English | 72.0 KB | ||
| 2012-10-23 17:40 |
VIVALIS PUBLIE SON CHIFFRE D'AFFAIRE ET SA SITUATION DE TRESORERIE POUR LE TROI…
|
French | 96.3 KB | ||
| 2012-10-23 17:40 |
VIVALIS ANNOUNCES 2012 THIRD QUARTER REVENUES AND CASH POSITION
|
English | 96.5 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
